$0.54
0.0191[3.67%]
At close: Apr 23
$0.54
0[0.00%]
PreMarket: 6:37PM EDT
Sangamo Therapeutics
(NASDAQ:SGMO)Latest News for Sangamo Therapeutics Stock (NASDAQ:SGMO)
Sangamo Therapeutics Stock (NASDAQ: SGMO)
Categories: All
Friday, March 22, 2024
- 12 Health Care Stocks Moving In Friday's Intraday SessionBenzinga Insights - Mar 22, 2024, 1:31PM
- Sangamo Therapeutics shares are trading lower after the company announced the pricing of a $24.0 million registered direct offering.Benzinga Newsdesk - Mar 22, 2024, 8:06AM
- Sangamo Therapeutics Announces Pricing Of $24M Registered Direct OfferingHappy Mohamed - Mar 22, 2024, 8:05AM
Tuesday, March 19, 2024
Thursday, March 14, 2024
Wednesday, March 13, 2024
- 4 Analysts Assess Sangamo Therapeutics: What You Need To KnowBenzinga Insights - Mar 13, 2024, 2:00PM
- HC Wainwright & Co. Maintains Buy on Sangamo Therapeutics, Maintains $3 Price TargetBenzinga Newsdesk - Mar 13, 2024, 12:48PM
- Sangamo Therapeutics Expects Total Operating Expenses In The Range Of ~$145M-$165M In 2024Benzinga Newsdesk - Mar 13, 2024, 8:16AM
- Sangamo Therapeutics Q4 EPS $(0.34) Misses $(0.26) Estimate, Sales $2.04M Miss $8.10M EstimateHappy Mohamed - Mar 13, 2024, 8:15AM
- Sangamo Therapeutics Announces Data From STAC-BBB Demonstrating 'robust penetration of the blood-brain barrier (BBB) and strong transgene expression throughout the central nervous system (CNS) of NHPs'Benzinga Newsdesk - Mar 13, 2024, 8:06AM
- Earnings Scheduled For March 13, 2024Benzinga Insights - Mar 13, 2024, 6:15AM
Monday, February 19, 2024
Monday, February 12, 2024
- HC Wainwright & Co. Reiterates Buy on Sangamo Therapeutics, Maintains $3 Price TargetBenzinga Newsdesk - Feb 12, 2024, 12:48PM
- 12 Health Care Stocks Moving In Monday's Intraday SessionBenzinga Insights - Feb 12, 2024, 12:31PM
- Sangamo Therapeutics shares are trading higher after the company announced FDA alignment on abbreviated pathway to potential approval and EMA PRIME eligibility for ST-920 in Fabry disease.Benzinga Newsdesk - Feb 12, 2024, 10:51AM
- Sangamo Therapeutics Announces FDA Alignment On Abbreviated Pathway To Potential Approval And EMA Prime Eligibility For ST-920 In Fabry DiseaseBenzinga Newsdesk - Feb 12, 2024, 8:06AM
Tuesday, February 06, 2024
Monday, February 05, 2024
- Sangamo Therapeutics Reports Updated Preliminary Data From Phase 1/2 STAAR Clinical Study Evaluating Isaralgagene Civaparvovec, Or ST-920; Says Productive Discussions Are Continuing With FDA On Pathways To RegistrationBenzinga Newsdesk - Feb 5, 2024, 6:09PM
- Sangamo Therapeutics Gets European Medicines Agency PRIME Designation For Isaralgagene Civaparvovec For Treatment Of Fabry DiseaseBenzinga Newsdesk - Feb 5, 2024, 2:33PM
Friday, January 19, 2024
- Deep Dive Into Sangamo Therapeutics Stock: Analyst Perspectives (4 Ratings)Benzinga Insights - Jan 19, 2024, 2:00PM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Jan 19, 2024, 8:06AM
- HC Wainwright & Co. Reiterates Buy on Sangamo Therapeutics, Maintains $3 Price TargetBenzinga Newsdesk - Jan 19, 2024, 6:59AM
Wednesday, January 10, 2024
Wednesday, November 15, 2023
Tuesday, November 07, 2023
Monday, November 06, 2023
- Where Sangamo Therapeutics Stands With AnalystsBenzinga Insights - Nov 6, 2023, 4:00PM
- HC Wainwright & Co. Maintains Buy on Sangamo Therapeutics, Lowers Price Target to $3Benzinga Newsdesk - Nov 6, 2023, 11:04AM
- What 8 Analyst Ratings Have To Say About Sangamo TherapeuticsBenzinga Insights - Nov 6, 2023, 10:00AM
- Wells Fargo Downgrades Sangamo Therapeutics to Equal-Weight, Announces $1 Price TargetBenzinga Newsdesk - Nov 6, 2023, 8:21AM
Friday, November 03, 2023
- Sangamo Therapeutics Inc Says Pfizer Expects A Pivotal Readout In The Phase 3 Affine Trial Evaluating Giroctocogene Fitelparvovec In The Middle Of 2024Benzinga Newsdesk - Nov 3, 2023, 4:10PM
- What To Know About RBC Capital's Downgrade of Sangamo TherapeuticsBenzinga Insights - Nov 3, 2023, 1:00PM
- RBC Capital Downgrades Sangamo Therapeutics to Sector Perform, Lowers Price Target to $2Benzinga Newsdesk - Nov 3, 2023, 6:20AM
Thursday, November 02, 2023
- Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - Nov 2, 2023, 2:26PM
- Sangamo Therapeutics shares are trading lower after the company reported worse-than-expected Q3 financial results.Benzinga Newsdesk - Nov 2, 2023, 12:42PM